advertisement
Melecchi A 11
Showing records 1 to 11 | Display all abstracts from Melecchi A108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Minnelli C
Pharmaceuticals (Basel, Switzerland) 2023; 16:
108575 Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis
Amato R
Cells 2023; 12:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Minnelli C
Pharmaceuticals (Basel, Switzerland) 2023; 16:
108575 Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis
Cammalleri M
Cells 2023; 12:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Piva F
Pharmaceuticals (Basel, Switzerland) 2023; 16:
108575 Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis
Melecchi A; Melecchi A
Cells 2023; 12:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Cecati M
Pharmaceuticals (Basel, Switzerland) 2023; 16:
108575 Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis
Bagnoli P
Cells 2023; 12:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Armeni T; Mobbili G; Mobbili G
Pharmaceuticals (Basel, Switzerland) 2023; 16:
108575 Natural History of Glaucoma Progression in the DBA/2J Model: Early Contribution of Müller Cell Gliosis
Porciatti V
Cells 2023; 12:
108509 Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Galeazzi R; Galeazzi R; Melecchi A; Melecchi A; Cristaldi M; Corsaro R; Rusciano D
Pharmaceuticals (Basel, Switzerland) 2023; 16:
